A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer
Clinical trial NCT05056116 · UNKNOWN
Trial details
- NCT number
- NCT05056116
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.